Antibiotics Market size was valued at USD 52.67 billion in 2023 to USD 72.65 billion by 2031, growing at a CAGR of 4.10% during the forecast period (2024-2031).Westford, USA, Sept. 23, 2024 (GLOBE ...
Rifabutin is a rifamycin antibiotic, a group of antibiotics that were first isolated in the 1950s. They are still widely used to treat mycobacteria and Gram-positive infections, but uptake into ...
5. Aemcolo® (rifamycin) is indicated for the treatment of travelers' diarrhea caused by noninvasive strains of Escherichia coli in adults. For full prescribing information see: www.Aemcolo.com.
5. Aemcolo® (rifamycin) is indicated for the treatment of travelers' diarrhea caused by noninvasive strains of Escherichia coli in adults. For full prescribing information see: www.Aemcolo.com.
Data, from a post hoc analysis of the randomized, placebo-controlled, double-blind phase 2/3 study of oral opaganib in COVID-19 pneumonia, showing a 62% reduction in mortality and a 21% improvement in ...